Clinical Trials Logo
  1. Home
  2. Soft Tissue Sarcomas
  3. NCT02636725

Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas

Soft Tissue Sarcomas Clinical Trial

Official title:
A Phase II Trial of Concurrent Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma (ASPS) and Other Soft Tissue Sarcomas (STS)

Clinical Trial Summary

The purpose of this research study is to test if Axitinib together with Pembrolizumab can slow tumor growth and know the side effects of the combination treatment.

Clinical Trial Description

Arm 2, the Axitinib Plus Pembrolizumab Expansion Cohort, did not open. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02636725
Study type Interventional
Source University of Miami
Contact
Status Completed
Phase Phase 2
Start date April 19, 2016
Completion date March 3, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT00385203 - The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). Phase 2
Terminated NCT02536183 - A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Phase 1
Recruiting NCT05739084 - Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS
Recruiting NCT00687778 - 11C-Acetate PET/CT Non-FDG-Avid Tumors N/A
Recruiting NCT04506008 - Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas Phase 2
Terminated NCT02575066 - Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients Phase 2
Completed NCT04223583 - Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule Phase 4
Recruiting NCT04425967 - Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas N/A
Not yet recruiting NCT03946943 - Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma Phase 2
Withdrawn NCT00881595 - Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas Phase 2
Completed NCT00423254 - Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Phase 1
Completed NCT00276302 - Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) Phase 1
Withdrawn NCT03149120 - Study of Nivolumab With or Without Pazopanib in Metastatic or Unresectable Soft Tissue Sarcomas Phase 2
Completed NCT01830153 - RAD001 in Advanced Sarcoma Phase 2